by European Organization for Research and Treatment of Cancer Malignant tumors of the peripheral nerve are rare but aggressive and very difficult to treat successfully. Now, researchers in the U.S. have shown that a combination of two types of anti-cancer drugs, MEK and SHP2 inhibitors, is effective in targeting the mechanism that drives the cancer’s growth. Although...
